Skip to main content
. 2023 Oct 27;102(43):e35798. doi: 10.1097/MD.0000000000035798

Table 2.

Relationship between receptor groups and serosal/visceral metastasis.

Variables Receptor group
ER and/or PR (+), HER2 (−) ER and/or PR (+), HER2 (+) ER (−), PR (−), HER2 (−) ER (−), PR (−), HER2 (+) P value
Non-special type of invasive carcinoma, n (%) 346 (76.4) 226 (91.5) 70 (81.4) 59 (88.1) <.001
Metastasis, n (%) 141 (31.1) 88 (35.6) 34 (39.5) 21 (31.3) <.001
Serosal metastasis 17 (3.8) 9 (3.6) 3 (3.5) 0 (0) .006
Visceral metastasis 70 (15.5) 52 (21.1) 14 (16.3) 17 (25.4) <.001
Serosal + visceral metastasis 54 (11.9) 27 (10.9) 17 (19.8) 4 (6) <.001